Dialysis dose as a determinant of adequacy

Seminars in Nephrology

Volumn 25, Issue 2, 2005, Pages 76-80

  Daugirdas, John T ^a   Greene, Tom ^a  

^a Department of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; UREA; UREMIC TOXIN;

ANTHROPOMETRY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BODY SIZE; BODY SURFACE; BODY WEIGHT; DISEASE ASSOCIATION; DOSE RESPONSE; FLUID BALANCE; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; HYPOTENSION; KIDNEY FAILURE; MORTALITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL;

EID: 15744373650     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.09.013     Document Type: Article

References (40)

1. A.R. Hull, T.F. Parker III Proceedings from the Morbidity, Mortality and Prescription of Dialysis Symposium, Dallas, TX, September 15-17, 1989 Am J Kidney Dis 15 1990 375 383
2. P.J. Held, F. Brunner, M. Odaka Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987 Am J Kidney Dis 15 1990 451 457
3. P.J. Held, C.E. Carroll, D.W. Liska Hemodialysis therapy in the United States What is the dose and does it matter? Am J Kidney Dis 24 1994 974 980
4. T. Greene, G.J. Beck, J.J. Gassman Design and statistical issues of the hemodialysis (HEMO) study Control Clin Trials 21 2000 502 525
5. G. Eknoyan, G.J. Beck, A.K. Cheung Hemodialysis (HEMO) Study Group Effect of dialysis dose and membrane flux in maintenance hemodialysis N Engl J Med 347 2002 2010 2019
6. J.S. Wong, F.K. Port, T.E. Hulbert-Shearon Survival advantage in Asian American end-stage renal disease patients Kidney Int 55 1999 2515 2523
7. P.J. Held, T. Akiba, N.S. Stearns Survival of middle aged dialysis patients in Japan and the US, 1988-89 E.A. Friedman Death on Hemodialysis Preventable or Inevitable? 1994 Kluwer Academic Boston, MA 13 23
8. W.F. Owen, N.L. Lew, Y. Liu The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis N Engl J Med 329 1993 1001 1006
9. P.J. Held, F.K. Port, R.A. Wolfe The dose of hemodialysis and patient mortality Kidney Int 50 1996 550 556
10. J.T. Daugirdas, T.A. Depner HEMO Study Group Asociation of achieved eKt/V with mortality An example of dose targeting bias J Am Soc Nephrol 13 2002 613A (abstr)
11. T. Greene, J. Daugirdas, A. Cheung HEMO Study Group Indices derived from modeled urea distribution volume (Vm) as associated with mortality in the HEMO study J Am Soc Nephrol 14 2003 212A (abstr)
12. T. Depner, J. Daugirdas, T. Greene Hemodialysis Study Group Dialysis dose and the effect of gender and body size on outcome in the HEMO Study Kidney Int 65 2004 1386 1394
13. K.L. Baird The new NIH and FDA medical research policies Targeting gender, promoting justice J Health Polit Policy Law 24 1999 531 565
14. W.F. Owen Jr, G.M. Chertow, J.M. Lazarus Dose of hemodialysis and survival Differences by race and sex JAMA 280 1998 1764 1768
15. Z. Li, N.L. Lew, J.M. Lazarus Comparing the urea reduction ratio and the urea product as outcome-based measures of hemodialysis dose Am J Kidney Dis 35 2000 598 605
16. T.H. Dawson Engineering Design of the Cardiovascular System of Mammals 1991 Prentice Hall Englewood Cliffs, NJ
17. E.H. Livingston, S. Lee Body surface area prediction in normal-weight and obese patients Am J Physiol 281 2001 E586 E591
18. J.T. Daugirdas, T. Greene, T.A. Depner Hemodialysis (HEMO) Study Group Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients Effects of age, race, and gender Kidney Int 64 2003 1108 1119
19. M.A. Singer, A.R. Morton Mouse to elephant Biological scaling and Kt/V Am J Kidney Dis 35 2000 306 309
20. F.K. Port, R.A. Wolfe, T.E. Hulbert-Shearon High dialysis dose is associated with lower mortality among women but not among men Am J Kidney Dis 43 2004 1014 1023
21. U.S. Renal Data System, USRDS Annual Data Reports: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 1994-2003
22. E. Arias United States Life Tables 2001 National Vital Statistics Reports (February 18, 2004) volume 52: number 14, 2004. Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr52/nvsr52_14.pdf. Accessed March 4, 2005
23. F.G. Casino, T. Lopez The equivalent renal urea clearance A new parameter to assess dialysis dose Nephrol Dial Transplant 11 1996 1574 1581
24. F.A. Gotch Evolution of the single-pool urea kinetic model Semin Dial 14 2001 252 256
25. R. Suri, T.A. Depner, P.G. Blake Adequacy of quotidian hemodialysis Am J Kidney Dis 42 suppl 1 2003 42 48
26. T.A. Depner Daily hemodialysis efficiency An analysis of solute kinetics Adv Ren Replace Ther 8 2001 227 235
27. D.I. Feig, T. Nakagawa, S.A. Karumanchi Hypothesis Uric acid, nephron number, and the pathogenesis of essential hypertension Kidney Int 66 2004 281 287
28. S.P. Hsu, M.F. Pai, Y.S. Peng Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients Nephrol Dial Transplant 19 2004 457 462
29. M. Ziolko, J.A. Pietrzyk, J. Grabska-Chrzastowska Accuracy of hemodialysis modeling Kidney Int 57 2000 1152 1163
30. R.C. Vanholder, G. Glorieux, R. De Smet Low molecular weight, water-soluble uremic toxins Adv Ren Replace Ther 10 2003 257 269
31. G.A. Block, T.E. Hulbert-Shearon, N.W. Levin Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients A national study Am J Kidney Dis 31 1998 607 617
32. I. Mucsi, G. Hercz Control of serum phosphate in patients with renal failure--new approaches Nephrol Dial Transplant 13 1998 2457 2460
33. G.M. Chertow, S.K. Burke, P. Raggi Treat to Goal Working Group Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Kidney Int 62 2002 245 252
34. A.P. Guerin, G.M. London, S.J. Marchais Arterial stiffening and vascular calcifications in end-stage renal disease Nephrol Dial Transplant 15 2000 1014 1021
35. I. Mucsi, G. Hercz, R. Uldall Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis Kidney Int 53 1998 1399 1404
36. C. Chazot, I. Chazot, B. Charra Functional study of hands among patients dialysed for more than 10 years Nephrol Dial Transplant 8 1993 347 351
37. R.N. Foley, P.S. Parfrey, G.M. Kent Long-term evolution of cardiomyopathy in dialysis patients Kidney Int 54 1998 1720 1725
38. B. Charra, M. Calemard, G. Laurent Importance of treatment time and blood pressure control in achieving long-term survival on dialysis Am J Nephrol 16 1996 35 44
39. A. Innes, B. Charra, R.P. Burden The effect of long, slow haemodialysis on patient survival Nephrol Dial Transplant 14 1999 919 922
40. K.S. Katzarski, B. Charra, A.J. Luik Fluid state and blood pressure control in patients treated with long and short haemodialysis Nephrol Dial Transplant 14 1999 369 375